{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T09:41:34Z","timestamp":1775727694278,"version":"3.50.1"},"reference-count":182,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Reprogramming of cellular energy metabolism is widely accepted to be a cancer hallmark. The deviant energetic metabolism of cancer cells-known as the Warburg effect-consists in much higher rates of glucose uptake and glycolytic oxidation coupled with the production of lactic acid, even in the presence of oxygen. Consequently, cancer cells have higher glucose needs and thus display a higher sensitivity to glucose deprivation-induced death than normal cells. So, inhibitors of glucose uptake are potential therapeutic targets in cancer. Breast cancer is the most commonly diagnosed cancer and a leading cause of cancer death in women worldwide. Overexpression of facilitative glucose transporters (GLUT), mainly GLUT1, in breast cancer cells is firmly established, and the consequences of GLUT inhibition and\/or knockout are under investigation. Herein we review the compounds, both of natural and synthetic origin, found to interfere with uptake of glucose by breast cancer cells, and the consequences of interference with that mechanism on breast cancer cell biology. We will also present data where the interaction with GLUT is exploited in order to increase the efficiency or selectivity of anticancer agents, in breast cancer cells.<\/jats:p>","DOI":"10.3390\/cancers12010154","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T03:07:11Z","timestamp":1578539231000},"page":"154","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":118,"title":["Targeting Glucose Transporters for Breast Cancer Therapy: The Effect of Natural and Synthetic Compounds"],"prefix":"10.3390","volume":"12","author":[{"given":"Ana M.","family":"Barbosa","sequence":"first","affiliation":[{"name":"Instituto de Ci\u00eancias Biom\u00e9dicas Abel Salazar, University of Porto, 4169-007 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0525-3416","authenticated-orcid":false,"given":"F\u00e1tima","family":"Martel","sequence":"additional","affiliation":[{"name":"Unit of Biochemistry, Department of Biomedicine, Faculty of Medicine, University of Porto, 4200-319 Porto, Portugal"},{"name":"Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, University of Porto, 4200-135 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2020,1,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Rossi, L., Stevens, D., Pierga, J.Y., Lerebours, F., Reyal, F., Robain, M., Asselain, B., and Rouzier, R. (2015). Impact of adjuvant chemotherapy on breast cancer survival: A real-world population. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132853"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S1470-2045(08)70179-7","article-title":"Cancer survival in five continents: A worldwide population-based study (CONCORD)","volume":"9","author":"Coleman","year":"2008","journal-title":"Lancet Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1042\/BJ20081258","article-title":"Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation","volume":"418","author":"Ahmad","year":"2009","journal-title":"Biochem. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1126\/science.1174229","article-title":"Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells","volume":"325","author":"Yun","year":"2009","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.4161\/cc.8.23.10238","article-title":"The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma","volume":"8","author":"Pavlides","year":"2009","journal-title":"Cell Cycle"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e213","DOI":"10.1186\/bcr2892","article-title":"Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment","volume":"13","author":"Sotgia","year":"2011","journal-title":"Breast Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ebiom.2019.02.025","article-title":"Oxidized ATM-mediated glycolysis enhancement in breast cancer-associated fibroblasts contributes to tumor invasion through lactate as metabolic coupling","volume":"41","author":"Sun","year":"2019","journal-title":"EBioMedicine"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e926729","DOI":"10.1155\/2014\/926729","article-title":"Autophagy, Warburg, and Warburg reverse effects in human cancer","volume":"2014","author":"Gonzalez","year":"2014","journal-title":"Biomed Res. Int."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.4161\/cc.10.15.16584","article-title":"Understanding the metabolic basis of drug resistance: Therapeutic induction of the Warburg effect kills cancer cells","volume":"10","author":"Lin","year":"2011","journal-title":"Cell Cycle"},{"key":"ref_13","first-page":"164","article-title":"Expression of glucose transporters in cancers","volume":"1835","author":"Szablewski","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1152\/physrev.00055.2009","article-title":"Biology of human sodium glucose transporters","volume":"91","author":"Wright","year":"2011","journal-title":"Physiol. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00424-003-1202-0","article-title":"The sodium\/glucose cotransport family SLC5","volume":"447","author":"Wright","year":"2004","journal-title":"Pflugers Arch."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pharmthera.2016.10.017","article-title":"The Na(+)-D-glucose cotransporters SGLT1 and SGLT2 are targets for the treatment of diabetes and cancer","volume":"170","author":"Koepsell","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.mam.2012.07.001","article-title":"The SLC2 (GLUT) family of membrane transporters","volume":"34","author":"Mueckler","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/jcp.20166","article-title":"Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer","volume":"202","author":"Macheda","year":"2005","journal-title":"J. Cell Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4067\/S0716-97602002000100004","article-title":"Glucose transporters: Expression, regulation and cancer","volume":"35","author":"Medina","year":"2002","journal-title":"Biol. Res."},{"key":"ref_20","first-page":"141","article-title":"Metabolic genes in cancer: Their roles in tumor progression and clinical implications","volume":"1805","author":"Furuta","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/BF02904704","article-title":"Role for glucose transporter 1 protein in human breast cancer","volume":"4","author":"Walsh","year":"1998","journal-title":"Pathol. Oncol. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2174\/187152008783961932","article-title":"The Warburg effect: Why and how do cancer cells activate glycolysis in the presence of oxygen?","volume":"8","year":"2008","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1124\/mol.117.110007","article-title":"Molecular Imaging of GLUT1 and GLUT5 in breast cancer: A multitracer positron emission tomography imaging study in mice","volume":"93","author":"Wuest","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10911-013-9310-8","article-title":"Biology of glucose transport in the mammary gland","volume":"19","author":"Zhao","year":"2014","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3168\/jds.2006-470","article-title":"Expression and regulation of glucose transporters in the bovine mammary gland","volume":"90","author":"Zhao","year":"2007","journal-title":"J. Dairy Sci."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1186\/s13058-016-0795-0","article-title":"The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis","volume":"18","author":"Wellberg","year":"2016","journal-title":"Breast Cancer Res."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Young, C.D., Lewis, A.S., Rudolph, M.C., Ruehle, M.D., Jackman, M.R., Yun, U.J., Ilkun, O., Pereira, R., Abel, E.D., and Anderson, S.M. (2011). Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023205"},{"key":"ref_28","first-page":"1279","article-title":"GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression","volume":"26","author":"Pinheiro","year":"2011","journal-title":"Histol. Histopathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s12253-012-9500-5","article-title":"Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers","volume":"18","author":"Krzeslak","year":"2012","journal-title":"Pathol. Oncol. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1210\/en.2003-0294","article-title":"Estrogen and progesterone up-regulate glucose transporter expression in ZR-75-1 human breast cancer cells","volume":"144","author":"Medina","year":"2003","journal-title":"Endocrinology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pharmthera.2008.09.005","article-title":"Nutrient transporters in cancer: Relevance to Warburg hypothesis and beyond","volume":"121","author":"Ganapathy","year":"2009","journal-title":"Pharmacol. Ther."},{"key":"ref_32","first-page":"170","article-title":"Hypoxia-Induced increase in FDG uptake in MCF7 cells","volume":"42","author":"Burgman","year":"2001","journal-title":"J. Nucl. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ijc.11387","article-title":"Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer","volume":"107","author":"Seger","year":"2003","journal-title":"Int. J. Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jdsr.2017.08.003","article-title":"Cancer metabolism: New insights into classic characteristics","volume":"54","author":"Kato","year":"2018","journal-title":"Jpn. Dent. Sci. Rev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1210\/en.2012-1558","article-title":"17beta-estradiol activates glucose uptake via GLUT4 translocation and PI3K\/Akt signaling pathway in MCF-7 cells","volume":"154","author":"Garrido","year":"2013","journal-title":"Endocrinology"},{"key":"ref_36","first-page":"1108","article-title":"Cisplatin suppresses the growth and proliferation of breast and cervical cancer cell lines by inhibiting integrin beta5-mediated glycolysis","volume":"6","author":"Wang","year":"2016","journal-title":"Am. J. Cancer Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/cbf.2905","article-title":"Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells","volume":"31","author":"Yang","year":"2013","journal-title":"Cell Biochem. Funct."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.yexcr.2016.01.008","article-title":"Modulation of the uptake of critical nutrients by breast cancer cells by lactate: Impact on cell survival, proliferation and migration","volume":"341","author":"Guedes","year":"2016","journal-title":"Exp. Cell Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1023\/B:BREA.0000025397.56192.e2","article-title":"Naringenin inhibits glucose uptake in MCF-7 breast cancer cells: A mechanism for impaired cellular proliferation","volume":"85","author":"Harmon","year":"2004","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.yexcr.2013.05.001","article-title":"Quercetin and epigallocatechin gallate inhibit glucose uptake and metabolism by breast cancer cells by an estrogen receptor-independent mechanism","volume":"319","author":"Moreira","year":"2013","journal-title":"Exp. Cell Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/jcp.24698","article-title":"Loss of GLUT4 induces metabolic reprogramming and impairs viability of breast cancer cells","volume":"230","author":"Garrido","year":"2015","journal-title":"J. Cell Physiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1152\/ajpendo.2002.282.3.E733","article-title":"Identification of a novel glucose transporter-like protein-GLUT-12","volume":"282","author":"Rogers","year":"2002","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00280-007-0480-1","article-title":"Glut-1 as a therapeutic target: Increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies","volume":"61","author":"Evans","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers6031769","article-title":"Drug resistance in cancer: An overview","volume":"6","author":"Housman","year":"2014","journal-title":"Cancers"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e88815","DOI":"10.1172\/jci.insight.88815","article-title":"GLUT3 upregulation promotes metabolic reprogramming associated with antiangiogenic therapy resistance","volume":"2","author":"Kuang","year":"2017","journal-title":"JCI Insight"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1470-2045(00)00257-6","article-title":"Clinical role of positron emission tomography in oncology","volume":"2","author":"Bomanji","year":"2001","journal-title":"Lancet Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1053\/j.seminoncol.2010.11.012","article-title":"Metabolic positron emission tomography imaging in cancer detection and therapy response","volume":"38","author":"Zhu","year":"2011","journal-title":"Semin. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.chembiol.2017.08.028","article-title":"Targeting metabolism for cancer therapy","volume":"24","author":"Luengo","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5528\/wjtm.v3.i2.37","article-title":"Inhibitors of glucose transport and glycolysis as novel anticancer therapeutics","volume":"3","author":"Qian","year":"2014","journal-title":"World J. Transl. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.bjc.6604554","article-title":"Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer","volume":"99","author":"Michelakis","year":"2008","journal-title":"Br. J. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.3389\/fnmol.2016.00122","article-title":"Tumor metabolism, the ketogenic diet and beta-hydroxybutyrate: Novel approaches to adjuvant brain tumor therapy","volume":"9","author":"Woolf","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e104511","DOI":"10.1016\/j.phrs.2019.104511","article-title":"Targeting glucose metabolism to suppress cancer progression: Prospective of anti-glycolytic cancer therapy","volume":"150","author":"Mahmoud","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1039\/C6MD00287K","article-title":"Anticancer agents interacting with membrane glucose transporters","volume":"7","author":"Granchi","year":"2016","journal-title":"Medchemcomm"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/mnfr.200700470","article-title":"Targeting of cancer energy metabolism","volume":"53","year":"2009","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"94ra70","DOI":"10.1126\/scitranslmed.3002394","article-title":"Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality","volume":"3","author":"Chan","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.canlet.2010.07.002","article-title":"Small compound inhibitors of basal glucose transport inhibit cell proliferation and induce apoptosis in cancer cells via glucose-deprivation-like mechanisms","volume":"298","author":"Liu","year":"2010","journal-title":"Cancer Lett."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"25677","DOI":"10.18632\/oncotarget.4499","article-title":"A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models","volume":"6","author":"Xintaropoulou","year":"2015","journal-title":"Oncotarget"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1007\/s00280-016-3007-9","article-title":"Inhibition of Glut1 by WZB117 sensitizes radioresistant breast cancer cells to irradiation","volume":"77","author":"Zhao","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1158\/1535-7163.MCT-12-0131","article-title":"A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo","volume":"11","author":"Liu","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/CAD.0000000000000529","article-title":"Blockade of GLUT1 by WZB117 resensitizes breast cancer cells to adriamycin","volume":"28","author":"Chen","year":"2017","journal-title":"Anticancer Drugs"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/cmdc.201600276","article-title":"Identification and Optimization of the First Highly Selective GLUT1 Inhibitor BAY-876","volume":"11","author":"Siebeneicher","year":"2016","journal-title":"ChemMedChem"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0014-5793(01)03309-9","article-title":"Bromodomain: An acetyl-lysine binding domain","volume":"513","author":"Zeng","year":"2002","journal-title":"FEBS Lett."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e1915","DOI":"10.1038\/s41467-019-09672-2","article-title":"A chemical toolbox for the study of bromodomains and epigenetic signaling","volume":"10","author":"Wu","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bcp.2014.07.021","article-title":"Energy restriction mimetic agents to target cancer cells: Comparison between 2-deoxyglucose and thiazolidinediones","volume":"92","author":"Kuntz","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.biopha.2018.03.008","article-title":"Effect of metformin on estrogen and progesterone receptor-positive (MCF-7) and triple-negative (MDA-MB-231) breast cancer cells","volume":"102","author":"Amaral","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"e2935","DOI":"10.1038\/ncomms3935","article-title":"Tumour-associated mutant p53 drives the Warburg effect","volume":"4","author":"Zhang","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"132","DOI":"10.5483\/BMBRep.2017.50.3.189","article-title":"Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells","volume":"50","author":"Oh","year":"2017","journal-title":"BMB Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.abb.2017.08.009","article-title":"Silencing of Glut1 induces chemoresistance via modulation of Akt\/GSK-3beta\/beta-catenin\/survivin signaling pathway in breast cancer cells","volume":"636","author":"Oh","year":"2017","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.canlet.2007.07.021","article-title":"Glut-1 antibodies induce growth arrest and apoptosis in human cancer cell lines","volume":"257","author":"Rastogi","year":"2007","journal-title":"Cancer Lett."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","article-title":"Metformin and reduced risk of cancer in diabetic patients","volume":"330","author":"Evans","year":"2005","journal-title":"BMJ"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s40495-015-0032-z","article-title":"Metformin treatment for the prevention and\/or treatment of breast\/mammary tumorigenesis","volume":"1","author":"Grossmann","year":"2015","journal-title":"Curr. Pharmacol. Rep."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1586\/erm.10.22","article-title":"Obesity, hyperinsulinemia and breast cancer: Novel targets and a novel role for metformin","volume":"10","author":"Wysocki","year":"2010","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.4161\/cc.26461","article-title":"Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer","volume":"12","author":"Marini","year":"2013","journal-title":"Cell Cycle"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/carcin\/bgy174","article-title":"Stem cell-like breast cancer cells with acquired resistance to metformin are sensitive to inhibitors of NADH-dependent CtBP dimerization","volume":"40","author":"Banerjee","year":"2019","journal-title":"Carcinogenesis"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e172425","DOI":"10.1016\/j.ejphar.2019.172425","article-title":"Metformin inhibits PPARdelta agonist-mediated tumor growth by reducing Glut1 and SLC1A5 expressions of cancer cells","volume":"857","author":"Ding","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature13110","article-title":"Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides","volume":"508","author":"Birsoy","year":"2014","journal-title":"Nature"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1080\/15384101.2016.1249545","article-title":"lncRNA NBR2 modulates cancer cell sensitivity to phenformin through GLUT1","volume":"15","author":"Liu","year":"2016","journal-title":"Cell Cycle"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"8806","DOI":"10.1073\/pnas.95.15.8806","article-title":"Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice","volume":"95","author":"Elstner","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2967\/jnumed.115.162016","article-title":"Troglitazone stimulates cancer cell uptake of 18F-FDG by suppressing mitochondrial respiration and augments sensitivity to glucose restriction","volume":"57","author":"Moon","year":"2016","journal-title":"J. Nucl. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2011.08.038","article-title":"Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells","volume":"670","author":"Fiume","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1021\/pr200790e","article-title":"Sorafenib-induced mitochondrial complex I inactivation and cell death in human neuroblastoma cells","volume":"11","author":"Bull","year":"2012","journal-title":"J. Proteome Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10549-013-2668-x","article-title":"Effects of sorafenib on energy metabolism in breast cancer cells: Role of AMPK-mTORC1 signaling","volume":"141","author":"Fumarola","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00280-012-2032-6","article-title":"Response to trastuzumab by HER2 expressing breast tumour xenografts is accompanied by decreased Hexokinase II, glut1 and [18F]-FDG incorporation and changes in 31P-NMR-detectable phosphomonoesters","volume":"71","author":"Smith","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_84","first-page":"603","article-title":"Stunning and its effect on 3H-FDG uptake and key gene expression in breast cancer cells undergoing chemotherapy","volume":"47","author":"Engles","year":"2006","journal-title":"J. Nucl. Med."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Abd-Rabou, A.A., Ahmed, H.H., and Shalby, A.B. (2019). Selenium overcomes doxorubicin resistance in their nano-platforms against breast and colon cancers. Biol. Trace Elem. Res.","DOI":"10.1007\/s12011-019-01730-6"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1158\/1078-0432.CCR-14-2258","article-title":"CDK 4\/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: Phase II activity, safety, and predictive biomarker assessment","volume":"21","author":"DeMichele","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"e13014","DOI":"10.1038\/s41598-019-49484-4","article-title":"Pre-treatment with the CDK4\/6 inhibitor palbociclib improves the efficacy of paclitaxel in TNBC cells","volume":"9","author":"Cretella","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1186\/s13046-018-0741-3","article-title":"The anti-tumor efficacy of CDK4\/6 inhibition is enhanced by the combination with PI3K\/AKT\/mTOR inhibitors through impairment of glucose metabolism in TNBC cells","volume":"37","author":"Cretella","year":"2018","journal-title":"J. Exp. Clin. Cancer. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"628","DOI":"10.18632\/oncotarget.197","article-title":"Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival","volume":"1","author":"Powe","year":"2010","journal-title":"Oncotarget"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2967\/jnumed.113.121327","article-title":"Propranolol inhibits glucose metabolism and 18F-FDG uptake of breast cancer through posttranscriptional downregulation of hexokinase-2","volume":"55","author":"Kang","year":"2014","journal-title":"J. Nucl. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/ijc.23321","article-title":"Apoptosis of estrogen-receptor negative breast cancer and colon cancer cell lines by PTP alpha and src RNAi","volume":"122","author":"Zheng","year":"2008","journal-title":"Int. J. Cancer"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1634\/theoncologist.2010-0408","article-title":"Current status of SRC inhibitors in solid tumor malignancies","volume":"16","author":"Puls","year":"2011","journal-title":"Oncologist"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1158\/0008-5472.CAN-14-2345","article-title":"Src inhibition blocks c-Myc translation and glucose metabolism to prevent the development of breast cancer","volume":"75","author":"Jain","year":"2015","journal-title":"Cancer Res."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"41600","DOI":"10.1074\/jbc.M111.240812","article-title":"Inhibition of glycolytic enzymes mediated by pharmacologically activated p53: Targeting Warburg effect to fight cancer","volume":"286","author":"Grinkevich","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ccr.2009.03.021","article-title":"Ablation of key oncogenic pathways by RITA-reactivated p53 is required for efficient apoptosis","volume":"15","author":"Grinkevich","year":"2009","journal-title":"Cancer Cell"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1092472","article-title":"In vivo activation of the p53 pathway by small-molecule antagonists of MDM2","volume":"303","author":"Vassilev","year":"2004","journal-title":"Science"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc839","article-title":"The phosphatidylinositol 3-Kinase AKT pathway in human cancer","volume":"2","author":"Vivanco","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/BJ20100750","article-title":"Akt inhibitors reduce glucose uptake independently of their effects on Akt","volume":"432","author":"Tan","year":"2010","journal-title":"Biochem. J."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1038\/onc.2012.529","article-title":"The PGC-1\/ERR signaling axis in cancer","volume":"32","author":"Deblois","year":"2013","journal-title":"Oncogene"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1210\/en.2016-1288","article-title":"HKDC1 is a novel hexokinase involved in whole-body glucose use","volume":"157","author":"Ludvik","year":"2016","journal-title":"Endocrinology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/bioinformatics\/btt606","article-title":"Inferring therapeutic targets from heterogeneous data: HKDC1 is a novel potential therapeutic target for cancer","volume":"30","author":"Li","year":"2014","journal-title":"Bioinformatics"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.3389\/fonc.2019.00290","article-title":"PGC1beta regulates breast tumor growth and metastasis by SREBP1-mediated HKDC1 expression","volume":"9","author":"Chen","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_103","first-page":"3936","article-title":"Inhibition of miRNA-34a promotes triple negative cancer cell proliferation by promoting glucose uptake","volume":"18","author":"Li","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1038\/s41388-019-0817-3","article-title":"The miR-186-3p\/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells","volume":"38","author":"He","year":"2019","journal-title":"Oncogene"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00018-018-2963-0","article-title":"Mitochondrial functions and melatonin: A tour of the reproductive cancers","volume":"76","author":"Seiva","year":"2019","journal-title":"Cell Mol. Life Sci."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/jpi.12210","article-title":"Melatonin uptake through glucose transporters: A new target for melatonin inhibition of cancer","volume":"58","author":"Hevia","year":"2015","journal-title":"J. Pineal Res."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Blask, D.E., Dauchy, R.T., Dauchy, E.M., Mao, L., Hill, S.M., Greene, M.W., Belancio, V.P., Sauer, L.A., and Davidson, L. (2014). Light exposure at night disrupts host\/cancer circadian regulatory dynamics: Impact on the Warburg effect, lipid signaling and tumor growth prevention. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0102776"},{"key":"ref_108","first-page":"1635","article-title":"Melatonin regulates tumor aggressiveness under acidosis condition in breast cancer cell lines","volume":"17","author":"Sonehara","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.biopha.2017.03.069","article-title":"Lack of effect of the procarcinogenic 17beta-estradiol on nutrient uptake by the MCF-7 breast cancer cell line","volume":"90","author":"Nunes","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"ref_110","first-page":"589","article-title":"Metabolic studies of estrogen- and tamoxifen-treated human breast cancer cells by nuclear magnetic resonance spectroscopy","volume":"49","author":"Neeman","year":"1989","journal-title":"Cancer Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.2967\/jnumed.110.074708","article-title":"17beta-estradiol augments 18F-FDG uptake and glycolysis of T47D breast cancer cells via membrane-initiated rapid PI3K-Akt activation","volume":"51","author":"Ko","year":"2010","journal-title":"J. Nucl. Med."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1080\/19768354.2018.1476408","article-title":"Inhibition of cell growth by cellular differentiation into adipocyte-like cells in dexamethasone sensitive cancer cell lines","volume":"22","author":"Kim","year":"2018","journal-title":"Anim. Cells Syst."},{"key":"ref_113","first-page":"1295","article-title":"Corticosteroids induce chemotherapy resistance in the majority of tumour cells from bone, brain, breast, cervix, melanoma and neuroblastoma","volume":"29","author":"Zhang","year":"2006","journal-title":"Int. J. Oncol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.3892\/mmr.2015.3920","article-title":"Antiproliferative effect of dexamethasone in the MCF-7 breast cancer cell line","volume":"12","author":"Buxant","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.3389\/fendo.2017.00323","article-title":"New insights into the mechanism of action of soluble Klotho","volume":"8","author":"Dalton","year":"2017","journal-title":"Front. Endocrinol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.1038\/onc.2008.292","article-title":"Klotho: A tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer","volume":"27","author":"Wolf","year":"2008","journal-title":"Oncogene"},{"key":"ref_117","first-page":"e504","article-title":"The hormone KL1: A regulator of breast cancer cell metabolism","volume":"21","author":"Davidov","year":"2019","journal-title":"Isr. Med. Assoc. J."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","article-title":"Insulin and insulin-like growth factor signalling in neoplasia","volume":"8","author":"Pollak","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.lfs.2004.09.039","article-title":"Insulin and nitric oxide stimulates glucose transport in human placenta","volume":"76","author":"Acevedo","year":"2005","journal-title":"Life Sci."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Agrawal, S., Luc, M., Ziolkowski, P., Agrawal, A.K., Pielka, E., Walaszek, K., Zduniak, K., and Wozniak, M. (2017). Insulin-induced enhancement of MCF-7 breast cancer cell response to 5-fluorouracil and cyclophosphamide. Tumour Biol., 39.","DOI":"10.1177\/1010428317702901"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1743-6109.2006.00127.x","article-title":"Lactate stimulates endothelial cell migration","volume":"14","author":"Beckert","year":"2006","journal-title":"Wound Repair Regen."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"23111","DOI":"10.1074\/jbc.M202487200","article-title":"Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis","volume":"277","author":"Lu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1158\/0008-5472.CAN-17-0492","article-title":"Lactic acid accumulation in the tumor microenvironment suppresses (18)F-FDG uptake","volume":"79","author":"Turkcan","year":"2019","journal-title":"Cancer Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.bbamcr.2015.02.020","article-title":"IL4 receptor alpha mediates enhanced glucose and glutamine metabolism to support breast cancer growth","volume":"1853","author":"Venmar","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s10549-012-2289-9","article-title":"Role of epidermal growth factor receptor in breast cancer","volume":"136","author":"Masuda","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1007\/s00259-017-3705-5","article-title":"Strong association of epidermal growth factor receptor status with breast cancer FDG uptake","volume":"44","author":"Lee","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Jung, K.H., Lee, E.J., Park, J.W., Lee, J.H., Moon, S.H., Cho, Y.S., and Lee, K.H. (2019). EGF receptor stimulation shifts breast cancer cell glucose metabolism toward glycolytic flux through PI3 kinase signaling. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0221294"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/nbu.12278","article-title":"The role of polyphenols in modern nutrition","volume":"42","author":"Williamson","year":"2017","journal-title":"Nutr. Bull."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5455\/jice.20160118062127","article-title":"Natural polyphenols: Influence on membrane transporters","volume":"5","author":"Hussain","year":"2016","journal-title":"J. Intercult. Ethnopharmacol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/mnfr.201200511","article-title":"Possible effects of dietary polyphenols on sugar absorption and digestion","volume":"57","author":"Williamson","year":"2013","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Losada-Echeberria, M., Herranz-Lopez, M., Micol, V., and Barrajon-Catalan, E. (2017). Polyphenols as promising drugs against main breast cancer signatures. Antioxidants, 6.","DOI":"10.3390\/antiox6040088"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"22578","DOI":"10.3390\/molecules201219864","article-title":"Chemoprevention of breast cancer by dietary polyphenols","volume":"20","author":"Mocanu","year":"2015","journal-title":"Molecules"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.3389\/fnut.2018.00025","article-title":"Antimetabolic effects of polyphenols in breast cancer cells: Focus on glucose uptake and metabolism","volume":"5","author":"Keating","year":"2018","journal-title":"Front. Nutr."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-016-3794-z","article-title":"Effect of polyphenols on glucose and lactate transport by breast cancer cells","volume":"157","author":"Martel","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_135","first-page":"6936","article-title":"Action of gossypol and rhodamine 123 on wild type and multidrug-resistant MCF-7 human breast cancer cells: 31P nuclear magnetic resonance and toxicity studies","volume":"50","author":"Jaroszewski","year":"1990","journal-title":"Cancer Res."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1089\/jmf.2006.9.28","article-title":"Genistein induces glucose-regulated protein 78 in mammary tumor cells","volume":"9","author":"Lim","year":"2006","journal-title":"J. Med. Food"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Uifalean, A., Schneider, S., Gierok, P., Ionescu, C., Iuga, C.A., and Lalk, M. (2016). The impact of soy isoflavones on MCF-7 and MDA-MB-231 breast cancer cells using a global metabolomic approach. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17091443"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1080\/01635581.2015.1002625","article-title":"The chemopreventive effect of the dietary compound kaempferol on the MCF-7 human breast cancer cell line is dependent on inhibition of glucose cellular uptake","volume":"67","author":"Azevedo","year":"2015","journal-title":"Nutr. Cancer"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.2967\/jnumed.112.115436","article-title":"Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1alpha activation","volume":"54","author":"Jung","year":"2013","journal-title":"J. Nucl. Med."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.lfs.2018.07.027","article-title":"Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction","volume":"208","author":"Jia","year":"2018","journal-title":"Life Sci."},{"key":"ref_141","first-page":"3786","article-title":"Regulatory effects of glabridin and quercetin on energy metabolism of breast cancer cells","volume":"44","author":"Li","year":"2019","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"5682","DOI":"10.1039\/C8FO01397G","article-title":"Suppressing glucose metabolism with epigallocatechin-3-gallate (EGCG) reduces breast cancer cell growth in preclinical models","volume":"9","author":"Wei","year":"2018","journal-title":"Food Funct."},{"key":"ref_143","first-page":"2293","article-title":"Phloridzin and phloretin inhibition of 2-deoxy-D-glucose uptake by tumor cells in vitro and in vivo","volume":"13","author":"Nelson","year":"1993","journal-title":"Anticancer Res."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Niedzwiecki, A., Roomi, M.W., Kalinovsky, T., and Rath, M. (2016). Anticancer efficacy of polyphenols and their combinations. Nutrients, 8.","DOI":"10.3390\/nu8090552"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"172533","DOI":"10.1016\/j.ejphar.2019.172533","article-title":"Selective pro-apoptotic and antimigratory effects of polyphenol complex catechin:lysine 1:2 in breast, pancreatic and colorectal cancer cell lines","volume":"859","author":"Silva","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.bmcl.2010.02.027","article-title":"Novel inhibitors of basal glucose transport as potential anticancer agents","volume":"20","author":"Zhang","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"e8323","DOI":"10.1038\/s41598-018-25524-3","article-title":"Curcumin decreases Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF1alpha inhibition","volume":"8","author":"Siddiqui","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.1186\/s13046-019-1351-4","article-title":"Cardamonin inhibits breast cancer growth by repressing HIF-1alpha-dependent metabolic reprogramming","volume":"38","author":"Jin","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"e9607590","DOI":"10.1155\/2019\/9607590","article-title":"The cytotoxic properties of Baeckea frutescens branches extracts in eliminating breast cancer cells","volume":"2019","author":"Shahruzaman","year":"2019","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jep.2014.03.013","article-title":"A Petiveria alliacea standardized fraction induces breast adenocarcinoma cell death by modulating glycolytic metabolism","volume":"153","author":"Hernandez","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Zhu, S., Wei, L., Lin, G., Tong, Y., Zhang, J., Jiang, X., He, Q., Lu, X., Zhu, D.D., and Chen, Y.Q. (2019). Metabolic alterations induced by Kudingcha lead to cancer cell apoptosis and metastasis inhibition. Nutr. Cancer, 1\u201312.","DOI":"10.1080\/01635581.2019.1645865"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1016\/S0021-9258(19)63372-7","article-title":"Cytochalasin B binding sites and glucose transport carrier in human erythrocyte ghosts","volume":"252","author":"Jung","year":"1977","journal-title":"J. Biol. Chem."},{"key":"ref_153","first-page":"1201","article-title":"Different mammalian facilitative glucose transporters expressed in Xenopus oocytes","volume":"49","author":"Keller","year":"1990","journal-title":"Biomed. Biochim. Acta"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.nucmedbio.2016.06.001","article-title":"Molecular mechanism of (18)F-FDG uptake reduction induced by genipin in T47D cancer cell and role of uncoupling protein-2 in cancer cell glucose metabolism","volume":"43","author":"Cho","year":"2016","journal-title":"Nucl. Med. Biol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"e590","DOI":"10.3389\/fphar.2019.00590","article-title":"Breaking glucose transporter 1\/pyruvate kinase M2 glycolytic loop is required for cantharidin inhibition of metastasis in highly metastatic breast cancer","volume":"10","author":"Pan","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bcp.2019.01.016","article-title":"Betulinic acid suppresses breast cancer aerobic glycolysis via caveolin-1\/NF-kappaB\/c-Myc pathway","volume":"161","author":"Jiao","year":"2019","journal-title":"Biochem. Pharmacol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1093\/carcin\/bgs216","article-title":"Cancer chemoprevention with dietary isothiocyanates mature for clinical translational research","volume":"33","author":"Singh","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"30151","DOI":"10.1074\/jbc.M802529200","article-title":"Benzyl isothiocyanate targets mitochondrial respiratory chain to trigger reactive oxygen species-dependent apoptosis in human breast cancer cells","volume":"283","author":"Xiao","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/mc.22988","article-title":"AKT-dependent sugar addiction by benzyl isothiocyanate in breast cancer cells","volume":"58","author":"Roy","year":"2019","journal-title":"Mol. Carcinog."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3945\/jn.111.155259","article-title":"Mechanisms of action of (n-3) fatty acids","volume":"142","author":"Calder","year":"2012","journal-title":"J. Nutr."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/mc.22151","article-title":"Docosahexaenoic acid attenuates breast cancer cell metabolism and the Warburg phenotype by targeting bioenergetic function","volume":"54","author":"Mouradian","year":"2015","journal-title":"Mol. Carcinog."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-pharmtox-010510-100611","article-title":"Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D","volume":"51","author":"Krishnan","year":"2011","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jnutbio.2017.10.013","article-title":"Vitamin D3 decreases glycolysis and invasiveness, and increases cellular stiffness in breast cancer cells","volume":"53","author":"Santos","year":"2018","journal-title":"J. Nutr. Biochem."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/biof.1116","article-title":"Potential role of tocotrienols in the treatment and prevention of breast cancer","volume":"40","author":"Sylvester","year":"2014","journal-title":"Biofactors"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1248\/bpb.b15-00306","article-title":"Anticancer effects of gamma-tocotrienol are associated with a suppression in aerobic glycolysis","volume":"38","author":"Parajuli","year":"2015","journal-title":"Biol. Pharm. Bull."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1620\/tjem.238.131","article-title":"D-Allose Inhibits Cancer Cell Growth by Reducing GLUT1 Expression","volume":"238","author":"Noguchi","year":"2016","journal-title":"Tohoku J. Exp. Med."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jfda.2017.03.009","article-title":"The apple polyphenol phloretin inhibits breast cancer cell migration and proliferation via inhibition of signals by type 2 glucose transporter","volume":"26","author":"Wu","year":"2018","journal-title":"J. Food Drug. Anal."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1039\/c3sc22205e","article-title":"Glucose conjugation for the specific targeting and treatment of cancer","volume":"4","author":"Calvaresi","year":"2013","journal-title":"Chem. Sci."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1158\/0008-5472.CAN-12-2072","article-title":"Targeted cancer therapy with a 2-deoxyglucose-based adriamycin complex","volume":"73","author":"Cao","year":"2013","journal-title":"Cancer Res."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1007\/s11095-019-2673-9","article-title":"Sugar modification enhances cytotoxic activity of PAMAM-Doxorubicin conjugate in glucose-deprived MCF-7 cells\u2014Possible role of GLUT1 transporter","volume":"36","author":"Sztandera","year":"2019","journal-title":"Pharm. Res."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"7428","DOI":"10.1021\/jm8006257","article-title":"Targeting the delivery of glycan-based paclitaxel prodrugs to cancer cells via glucose transporters","volume":"51","author":"Lin","year":"2008","journal-title":"J. Med. Chem."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1039\/c3cc38589b","article-title":"Highly water-soluble platinum(II) complexes as GLUT substrates for targeted therapy: Improved anticancer efficacy and transporter-mediated cytotoxic properties","volume":"49","author":"Liu","year":"2013","journal-title":"Chem. Commun. Camb."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cmet.2014.05.004","article-title":"The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function","volume":"20","author":"Macintyre","year":"2014","journal-title":"Cell Metab."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1158\/0008-5472.CAN-12-1949","article-title":"Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay","volume":"72","author":"Fiaschi","year":"2012","journal-title":"Cancer Res."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/1574892811666160415160104","article-title":"Glycolysis inhibitors for anticancer therapy: A review of recent patents","volume":"11","author":"Sheng","year":"2016","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10637-006-9019-2","article-title":"A phase I and pharmacokinetic study of silybin-phytosome in prostate cancer patients","volume":"25","author":"Flaig","year":"2007","journal-title":"Investig. New Drugs"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00280-012-2045-1","article-title":"A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors","volume":"71","author":"Raez","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.bbabio.2010.10.012","article-title":"Choosing between glycolysis and oxidative phosphorylation: A tumor\u2019s dilemma?","volume":"1807","author":"Jose","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.fct.2016.08.033","article-title":"Cisplatin and resveratrol induce apoptosis and autophagy following oxidative stress in malignant mesothelioma cells","volume":"97","author":"Lee","year":"2016","journal-title":"Food Chem. Toxicol."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"454","DOI":"10.2174\/1568026618666180523105234","article-title":"Targeting key transporters in tumor glycolysis as a novel anticancer strategy","volume":"18","author":"Shi","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_181","doi-asserted-by":"crossref","unstructured":"Garcia-Aranda, M., and Redondo, M. (2019). Immunotherapy: A challenge of breast cancer treatment. Cancers, 11.","DOI":"10.3390\/cancers11121822"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/jnnp-2015-311475","article-title":"Triheptanoin dramatically reduces paroxysmal motor disorder in patients with GLUT1 deficiency","volume":"87","author":"Mochel","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/1\/154\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T13:42:30Z","timestamp":1760362950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/1\/154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,8]]},"references-count":182,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1]]}},"alternative-id":["cancers12010154"],"URL":"https:\/\/doi.org\/10.3390\/cancers12010154","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,8]]}}}